| Dr Jessica Lynn Pasko, MD | |
|
107 S Sporting Hill Rd, Mechanicsburg, PA 17050-3058 | |
| (717) 943-1781 | |
| Not Available |
| Full Name | Dr Jessica Lynn Pasko |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 107 S Sporting Hill Rd, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083842025 | NPI | - | NPPES |
| 391960 | Other | PA | MEDICARE FQHC |
| 1029596620001 | Medicaid | PA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Pennsylvania Medical Group Pllc | 5193900280 | 148 |
| Meritus Urgent Care Llc | 2163582974 | 21 |
News Archive
When it comes to improving the quality of life for people with mental health and substance use disorders, improvisational comedy is no joke. Just ask Rutgers School of Public Health student Mark Lee, who teaches vulnerable populations to gain confidence, communicate better, be spontaneous and trust others through improvisational exercises.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA's review to be completed in the first half of 2013.
Researchers at the Centro de Gen-mica e Investigaci-n Oncol-gica (GENYO) -of which the University of Granada, Pfizer and the Andalusian Regional Government are members- have identified the genetic and phenotypic changes that cause tumor progression and metastasis.
Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.
› Verified 2 days ago
| Entity Name | Patient First Pennsylvania Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194039560 PECOS PAC ID: 5193900280 Enrollment ID: O20110505000465 |
News Archive
When it comes to improving the quality of life for people with mental health and substance use disorders, improvisational comedy is no joke. Just ask Rutgers School of Public Health student Mark Lee, who teaches vulnerable populations to gain confidence, communicate better, be spontaneous and trust others through improvisational exercises.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA's review to be completed in the first half of 2013.
Researchers at the Centro de Gen-mica e Investigaci-n Oncol-gica (GENYO) -of which the University of Granada, Pfizer and the Andalusian Regional Government are members- have identified the genetic and phenotypic changes that cause tumor progression and metastasis.
Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Lynn Pasko, MD 13620 Crayton Blvd Ste A, Hagerstown, MD 21742-2335 Ph: (240) 313-3100 | Dr Jessica Lynn Pasko, MD 107 S Sporting Hill Rd, Mechanicsburg, PA 17050-3058 Ph: (717) 943-1781 |
News Archive
When it comes to improving the quality of life for people with mental health and substance use disorders, improvisational comedy is no joke. Just ask Rutgers School of Public Health student Mark Lee, who teaches vulnerable populations to gain confidence, communicate better, be spontaneous and trust others through improvisational exercises.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA's review to be completed in the first half of 2013.
Researchers at the Centro de Gen-mica e Investigaci-n Oncol-gica (GENYO) -of which the University of Granada, Pfizer and the Andalusian Regional Government are members- have identified the genetic and phenotypic changes that cause tumor progression and metastasis.
Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.
› Verified 2 days ago
Jafar Aljazeeri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050 Phone: 717-988-5864 Fax: 717-221-5615 | |
Dr. Clifford C Cloonan, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 6481 Carlisle Pike, Mechanicsburg, PA 17050 Phone: 717-516-6396 Fax: 717-620-8093 | |
Jeffrey Alan Matzoni, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Market Plaza Way, Suite 302, Mechanicsburg, PA 17055 Phone: 717-766-0228 Fax: 717-766-8122 | |
Navitha Ramesh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050 Phone: 717-988-5864 Fax: 717-221-5615 | |
Reinaldo Garcia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050 Phone: 717-988-5864 Fax: 717-221-5615 | |
Dr. Soni Srivastav, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy, Suite 440, Mechanicsburg, PA 17050 Phone: 717-791-2540 Fax: 717-791-2549 |